AL
AOR icon

Aspiriant LLC’s iShares Core 60/40 Balanced Allocation ETF AOR Stock Holding History

Aspiriant LLC’s Portfolio AOR Stock Details AOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.8M Buy
515,345
+5,921
+1% +$403K 0.88% 19
2026
Q1 		$32.8M Buy
509,424
+28,095
+6% +$1.85M 0.93% 18
2025
Q4 		$31.3M Buy
481,329
+15,686
+3% +$1.02M 0.9% 20
2025
Q3 		$30M Buy
465,643
+13,448
+3% +$841K 0.92% 20
2025
Q2 		$27.8M Sell
452,195
-11,733
-3% -$685K 0.88% 21
2025
Q1 		$26.7M Buy
463,928
+37,047
+9% +$2.16M 0.93% 16
2024
Q4 		$24.5M Sell
426,881
-17,564
-4% -$1.03M 0.88% 17
2024
Q3 		$26.3M Sell
444,445
-3,309
-0.7% -$190K 1% 16
2024
Q2 		$25.2M Buy
447,754
+32,854
+8% +$1.82M 1.03% 16
2024
Q1 		$23.1M Sell
414,900
-49,052
-11% -$2.65M 0.96% 17
2023
Q4 		$24.7M Sell
463,952
-56,750
-11% -$2.86M 1.11% 17
2023
Q3 		$25.7M Buy
520,702
+34,717
+7% +$1.77M 1.32% 15
2023
Q2 		$25M Buy
485,985
+14,519
+3% +$731K 1.26% 15
2023
Q1 		$23.6M Sell
471,466
-167,003
-26% -$8.22M 1.23% 15
2022
Q4 		$30.1M Sell
638,469
-1,104,893
-63% -$52M 1.53% 11
2022
Q3 		$78.1M Buy
1,743,362
+394,690
+29% +$19.1M 3.82% 6
2022
Q2 		$64.7M Buy
1,348,672
+1,175,314
+678% +$59.2M 3.12% 6
2022
Q1 		$9.35M Buy
173,358
+32,108
+23% +$1.75M 0.51% 26
2021
Q4 		$8.06M Buy
141,250
+47,949
+51% +$2.72M 0.43% 31
2021
Q3 		$5.17M Buy
93,301
+11,260
+14% +$635K 0.3% 42
2021
Q2 		$4.59M Buy
82,041
+28,166
+52% +$1.56M 0.26% 42
2021
Q1 		$2.89M Buy
53,875
+16,076
+43% +$855K 0.18% 53
2020
Q4 		$1.97M Buy
37,799
+12,593
+50% +$634K 0.13% 66
2020
Q3 		$1.22M Buy
+25,206
New +$1.22M 0.1% 87

Other funds holding AOR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
WAM
Worth Asset Management Dallas, Texas $313M AUM 37.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CWA
Consilium Wealth Advisory Richardson, Texas $337M AUM 37.76% 1-Year Est. Return
JSA
Jim Saulnier & Associates Fort Collins, Colorado $249M AUM 12.24% 1-Year Est. Return

Aspiriant LLC's AOR Position: Q2 2026 in Review

Aspiriant LLC increased its iShares Core 60/40 Balanced Allocation ETF (AOR) stake by 1.2% in Q2 2026, buying an estimated $403K and bringing the position to 515,345 shares worth $35.8M. The position accounts for 0.88% of the portfolio, ranked #19.

Aspiriant LLC first reported a position in AOR in Q3 2020 and has held it in 24 quarters since. The position peaked at $78.1M in Q3 2022. 452 funds tracked by Wall St. Rank hold AOR as of Q2 2026.

  • Aspiriant LLC held 515,345 shares of iShares Core 60/40 Balanced Allocation ETF worth $35.8M as of Q2 2026.
  • Aspiriant LLC bought 5,921 iShares Core 60/40 Balanced Allocation ETF shares in Q2 2026, an estimated $403K.
  • iShares Core 60/40 Balanced Allocation ETF made up 0.88% of Aspiriant LLC's portfolio in Q2 2026, its #19 holding.
  • Aspiriant LLC first reported a position in iShares Core 60/40 Balanced Allocation ETF in Q3 2020 and has held it in 24 quarters since.
  • Aspiriant LLC's iShares Core 60/40 Balanced Allocation ETF position peaked at $78.1M in Q3 2022.
  • 452 funds tracked by Wall St. Rank held iShares Core 60/40 Balanced Allocation ETF as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.